ADVERTISEMENT
News
debritom+ - Medaxis AG
06/19/2024
A 13-patient randomized, controlled, open-label pilot study comparing Debritom+ with sharp debridement was published. The results may indicate a modestly faster reduction in wound area with Debritom+ and provide feasibility for a sufficiently powered multi-center trial. JWC